{"schema_version":"secwatch.filing_event.v1","accession":"0001051514-23-000009","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2023-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.675980+00:00","generated_at":"2026-06-20T03:23:08.647216+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"STRATA reports record FY2022 revenue of $35-36M, up 17-19% YoY","bullets":["Preliminary unaudited full-year 2022 revenue of $35-36M, vs $30M in 2021.","Revenue at upper end of prior guidance of $33-35M.","Growth driven by XTRAC usage, device redeployment, and international sales.","Full audited results expected in March 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001051514-23-000009","json":"https://secwatch.observer/filing/0001051514-23-000009.json","markdown":"https://secwatch.observer/filing/0001051514-23-000009.md","text":"https://secwatch.observer/filing/0001051514-23-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000105151423000009/0001051514-23-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000105151423000009/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T03:23:08.647216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f6855dd7c332c7993342e456acd800865cb542c","claim":"STRATA Skin Sciences, Inc. reported the 2022 fiscal year results: revenue $35-$36 million. Guidance reaffirmed.","evidence_excerpt":"2 ex_99-1.htm STRATA PRESS RELEASE DATED 2/1/2023 Exhibit 99.1 STRATA Skin Sciences Expects Record Full Year 2022 Revenue ● Unaudited, preliminary revenue within the range of $35-$36 million ● Record revenue represents approximately 17-19% growth over full year 2021 HORSHAM, Pa., February 1, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151423000009/0001051514-23-000009-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the 2022 fiscal year"},{"label":"Revenue","value":"$35-$36 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}